Oxygen Biotherapeutics, Inc. OXBT today announced that it has
reached a tentative oral settlement of all litigation pending between the
Company and Tenor Opportunity Master Fund, Ltd., Aria Opportunity Fund, Ltd.
and Parsoon Opportunity Fund, Ltd. (collectively "Tenor"). The litigation,
filed by Tenor on August 30, 2011 in the United States District Court for the
Southern District of New York, alleged that a right of first offer held by
Tenor was breached in connection with the Company's June 2011 financing. The
tentative agreement provides that the Company will settle the matter for
$600,000 in cash, payable in six quarterly installments commencing on the date
the parties execute a written settlement agreement. The settlement is subject
to completion of a written settlement agreement encapsulating this oral
understanding, including other key items such as the process by which payments
are made, Tenor's recourse mechanisms should the payments not be made and
other important details. The written settlement agreement is also subject to
review and approval, in their absolute and sole discretion, by Tenor's
Investment Committee and the Company's Board. The Company admits no wrongdoing
as part of the settlement.
“We are very pleased to have reached this oral settlement agreement.
Settlement of this suit is a positive step forward for the company, allowing
us to focus on our core objectives of developing our perfluorocarbon-based
products without the distraction and additional legal fees further litigation
of this matter would have generated,” said Michael B. Jebsen, Chief Financial
Officer, President and Interim Chief Executive Officer of Oxygen.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in